aTYR PHARMA INC Public Float
aTYR PHARMA INC (ATYR) had Public Float of $463.82 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $463.82M.
- 2024-06-30: Entity Public Float $116.24M.
- 2023-06-30: Entity Public Float $120.77M.
- 2022-06-30: Entity Public Float $77.19M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $463.82M 10-K · filed 2026-03-05 |
| 2024-06-30 | $116.24M 10-K · filed 2025-03-13 |
| 2023-06-30 | $120.77M 10-K · filed 2024-03-14 |
| 2022-06-30 | $77.19M 10-K · filed 2023-03-14 |
| 2021-06-30 | $76.20M 10-K · filed 2022-03-15 |
| 2020-06-30 | $25.39M 10-K · filed 2021-03-24 |
| 2019-06-28 | $10.21M 10-K · filed 2020-03-26 |
| 2018-06-30 | $20.61M 10-K · filed 2019-03-26 |
| 2017-06-30 | $45.34M 10-K · filed 2018-03-20 |
| 2016-06-30 | $37.20M 10-K · filed 2017-03-16 |
| 2015-06-30 | $282.40M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |